Product Liability Reform: SB 344 (1995)

|

Bars application of the rule of joint and several liability


Bars application of the rule of joint and several liability in product liability cases.  Provides statutory defenses to product liability claims, including adherence to government standards, FDA standards, and sellers’ defenses.  Provides an absolute defense, where the plaintiff was found to be at least 50% at fault due to intoxication or a controlled substance.  Limits the award of noneconomic damages in product liability cases not involving death or loss of vital bodily function to $280,000.  Limits the award of noneconomic damages in such cases to $500,000.

Latest News

View all news

SCOTUS Should Affirm Federal Law Supremacy With FDA Authority Case

The U.S. Supreme Court has a chance to rein in state court rulings that impose liability on pharmaceutical companies that go beyond, and even contradict, the federal regulatory process of the FDA, according to Tiger Joyce, president of the American Tort Reform Association. He explains why it is imperative the high court review a case involving Janssen Pharmaceuticals.